Abstract

Lung cancer is the leading cause of cancer related deaths both in developed and developing countries. Since majority of the existing therapeutic methods harms both normal and malignant cells, a viable alternative is to switch into safe and beneficial traditional medicinal plants. Hence the present study was framed to identify selective anti-lung cancer agents from the medicinal plant Grewia tiliaefolia (GT). Cell viability experiments showed that benzene extract of GT (BGT) leaf effectively inhibited the growth of A549 cells, while being non-toxic to normal human lung L132 and PBMC cells. Ames and comet assays demonstrated that BGT is of non-mutagenic and non-genotoxic nature in untransformed cells. The hematological and histopathological profiles of the in vivo acute and sub-acute toxicity studies demonstrated that BGT is safe and tolerable. Importantly, western blot analysis and Annexin V-FITC staining confirmed that BGT promotes mitochondrial dependent apoptotic cell death in A549 cells by arresting cell cycle at G2/M phase. Bio-assay guided fractionation revealed the presence of phytosteols (β-sitosterol and daucosterol) which significantly inhibited the growth of A549 cells both alone and in combination. This study warrants that these phytosterols in alone or in combination can be considered as safe and potential drug candidates for lung cancer treatment.

Highlights

  • In the last decades, cancer research has enormously increased due to the rapid increase of cancer related death around the world

  • A549, PC3 and MCF-7 cells were evaluated by MTT assay and it confirms that benzene extract of G. tiliaefolia leaf (BGT) significantly inhibits the proliferation of A549 cells by a concentration and time dependent manner when compared with the other solvent extracts

  • Through the cytotoxic experiments it was observed that the benzene extract of the plant (BGT) has significant anti-proliferative effect against A549 cells without causing any harmful effect to the normal human lung (L132) and PBMC cells

Read more

Summary

Introduction

Cancer research has enormously increased due to the rapid increase of cancer related death around the world. In the current scenario, potential therapeutic agents are needed which could target only the cancer cells without causing harmful effects to the normal human cells. In this regards natural products offers large platform for the development of new drugs or small molecules against cancers, which are safe and devoid of toxicity. To provide scientific evidence, the present study has been designed to screen the Indian traditional medicinal plant Grewia tiliaefolia leaf against human lung cancer cells and to identify the anticancer agents present in it. In the present study we have aimed to study the anticancer potential of GT leaf extract against human non-small cell lung cancer (NSCLC) A549 cells, elucidate its mechanism and identify the active principle compounds

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call